PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...

Feb 3(Reuters) - Pfizer on Tuesday said an experimental obesity drug acquired through its $10 billion Metsera purchase showed sustained weight loss at 28 weeks as a monthly injection, and the U.S.

China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more ...

Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12. In ...

NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

In early March 2026, Pfizer reported past Phase 2 trial results showing its investigational trispecific antibody tilrekimig significantly improved eczema severity versus placebo in adults with ...